Results 81 to 90 of about 17,804 (213)

Cause‐specific mortality after a diagnosis of ductal carcinoma in situ: Associations with screening and socio‐economic status

International Journal of Cancer, Volume 158, Issue 4, Page 873-883, 15 February 2026.
What's new? Ductal carcinoma in situ (DCIS) fails to progress to invasive breast cancer (IBC) in about four‐fifths of women. Nonetheless, once advanced to IBC, risk of death increases. Here, the authors investigated breast cancer mortality in Dutch women with DCIS in light of potential associations with socioeconomic status (SES) and DCIS detection ...
Renée S. J. M. Schmitz, Alexandra W. van den Belt‐Dusebout, Maartje van Seijen, Ellen A. J. Verschuur, Frederieke H. van Duijnhoven, Michael Schaapveld, Esther H. Lips, Jelle Wesseling, Marjanka K. Schmidt   +8 more
wiley   +1 more source

Poorly differentiated high-grade urothelial carcinoma presenting as Paget's disease of the vulva with no overt urinary tract neoplasm detected

Gynecologic Oncology Reports, 2017
Objective: There are few reported cases of secondary (non-cutaneous) vulvar Paget's disease related to urothelial carcinoma (UC), with only 7 of them presenting initially with Paget's disease and up to a 13-year lapse from detecting a urinary tract ...
Radha R. Padhy, Niloo Nasseri-Nik, Fouad Abbas   +2 more
doaj   +1 more source

An Asymptomatic Lesion on the Penis

JEADV Clinical Practice, EarlyView.
Brandon Tan, Karen Cheung, Xin Liu, Alexis Daniel Lara Rivero   +3 more
wiley   +1 more source

Nipple‐Originating Solid Papillary Carcinoma In Situ: A Case Report and Literature Review

Clinical Case Reports, Volume 14, Issue 2, February 2026.
ABSTRACT Solid papillary carcinoma of the breast is a rare histopathological subtype of papillary neoplasms, and its in situ variant localized to the nipple is particularly uncommon. Current oncology literature provides limited evidence on standardized diagnostic criteria, biological behavior, and optimal treatment strategies for this entity.
Yuying Yang, Xiaoliang Hao, Yuanyuan Zhai, Xiaoping Xie, Xiaodong Ma   +4 more
wiley   +1 more source

Bone Metastases from Gastric Cancer Resembling Paget’s Disease: A Case Report [PDF]

, 2022
Hisaki Aiba, Tomoharu Nakazato, Hideo Matsuo, Hiroaki Kimura, Shiro Saito, Takao Sakai, Hideki Murakami, Jun Kawai, Shingo Kawasaki, Yasuhiro Imamura   +9 more
openalex   +1 more source

Bone Metastasis: Molecular Mechanisms, Clinical Management, and Therapeutic Targets

MedComm, Volume 7, Issue 2, February 2026.
This figure emphasizes current understanding of the regulatory networks, approach of diagnose, available preclinical models and clinical management of bone metastasis. to guide future therapeutic development. A deep understanding of these aspects enables the prevention of bone metastasis and the implementation of effective therapeutic strategies ...
Jingyuan Wen, Binghua Li, Shengjia Wang, Yongzhong Yao, Zhao Huang, Decai Yu   +5 more
wiley   +1 more source

Proteomic Signatures Over Age Reveal Significant Changes From Infancy Till Late Adulthood

Advanced Biology, Volume 10, Issue 1, January 2026.
Age‐specific changes in the serum proteome were investigated across the entire lifespan, from infancy till late adulthood by analyzing 178 proteins in serum samples of healthy individuals. Using various analyses approaches, distinct protein expression profiles and four protein patterns during aging were identified.
Eveline M. Delemarre, Hidde M. Smits, Debbie van Baarle, Marlies A. van Houten, Fiona R. M. van der Klis, Helen L. Leavis, Joel A. G. van Roon, Lilly M. Verhagen, Joanne G. Wildenbeest, Femke van Wijk, Julia Drylewicz, Stefan Nierkens   +11 more
wiley   +1 more source

Paget's disease of bone-associated osteosarcoma: molecular basis, signs and symptoms, treatment and research [PDF]

, 2015
Darrell Green is a Big C-funded molecular biologist at the University of East Anglia, performing research towards a PhD. He works with Professor Tamas Dalmay, Head of Biological Sciences and Chair of RNA Biology at the University of East Anglia and ...
Dalmay, Tamas, Fraser, William, Green, Darrell   +2 more
core  

Glucocorticoid Receptor Activation Reprograms NK Cells to Drive AREG‐Mediated Immunosuppression: A Pan‐Cancer Role for AREG

Advanced Science, Volume 13, Issue 2, 9 January 2026.
Natural killer cells, central to anti‐tumor defense, undergo unexpected reprogramming within the tumor microenvironment. Instead of producing IFN‐γ and TNF‐α, they elevate amphiregulin, a tumor‐promoting factor. This shift is linked to glucocorticoid receptor activity and prostaglandin signaling.
Qin Wei, Guirong Liang, Rui zeng, Yuancheng Li, Anlan Hong, Hongsheng Wang, Suying Feng, Yan Wang, Yetao Wang   +8 more
wiley   +1 more source